GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
May 30, 2023 07:01 ET
|
GreenLight Biosciences
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive...
GreenLight Biosciences Releases Inaugural Sustainability Report
April 12, 2023 06:59 ET
|
GreenLight Biosciences
BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world’s...
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
February 28, 2023 09:21 ET
|
Cytek Biosciences, Inc.
SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly...
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
February 01, 2023 07:20 ET
|
GreenLight Biosciences
The Rwanda FDA has given regulatory approval to GreenLight to start a Phase I/II clinical trial of its Covid-19 vaccine candidate in Rwanda. This phase I/II clinical trial is the first step in...
New funding announced to upgrade Canada’s biocontainment facilities
November 16, 2022 17:00 ET
|
Canada Foundation for Innovation
OTTAWA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The COVID-19 pandemic taught us that to tackle emerging global health issues countries must remain at the forefront of research. In Canada, this includes...
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022 16:30 ET
|
Cytek Biosciences, Inc.
Experienced Biotech, Pharmaceutical Industry Leader to Guide Operations Growth and Scalability FREMONT, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today...
CALADRIUS BIOSCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of CLBS and Encourages Investors to Contact the Firm
May 02, 2022 13:08 ET
|
Bragar Eagel & Squire
NEW YORK, May 02, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
Atreca Announces Appointment of Dr. Stacey Ma and Stephen R. Brady to its Board of Directors
July 19, 2021 16:30 ET
|
Atreca, Inc.
SAN CARLOS Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique...
Cytek® Biosciences Appoints Allen Poirson as Senior Vice President of Marketing and Corporate Development
April 28, 2021 10:00 ET
|
Cytek Biosciences
FREMONT, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc., a leading life sciences technology company, today announced that Allen Poirson, Ph.D. has been appointed as the senior...
Cytek Biosciences Completes Series D Funding Round
November 05, 2020 10:00 ET
|
Cytek Biosciences
FREMONT, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Cytek Biosciences Inc., a leading provider of cell analysis instrumentation and solutions, today announced that it has closed a $120 million Series...